1. Improving medication compliance. Proc Symposium November 1, 1984. Reston, VA: National Pharmaceutical Council. (See especially the chapter by Burrell CD and Levy RA entitled “Therapeutic consequences of noncompliance,” pp 7–16.).
2. US v Johnson, 221 US 488 (1911). [For a probing discussion of the impact of this Supreme Court decision on US drug regulation, see Temin P, ed. Taking your medicine. Drug regulation in the United States. Cambridge, MA: Harvard University Press; 1980: 32–37.].
3. The Lipid Research Clinics Coronary Primary Prevention Trial Results